eosinophilic esophagitis
Information
- Disease name
- eosinophilic esophagitis
- Disease ID
- DOID:13922
- Description
- "An esophagitis characterized by inflammation involving eosinophils located_in esophagus." [url:http\://en.wikipedia.org/wiki/Eosinophilic_esophagitis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05309590 | Active, not recruiting | Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children | May 2014 | May 2025 | |
| NCT05083156 | Active, not recruiting | Cow's Milk Elimination for Treatment of Eosinophilic Esophagitis | March 2012 | December 2025 | |
| NCT04753697 | Active, not recruiting | Phase 3 | A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis | February 22, 2021 | October 2, 2024 |
| NCT05247866 | Active, not recruiting | Phase 4 | Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis | June 16, 2022 | December 18, 2024 |
| NCT03822325 | Active, not recruiting | Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis | February 2011 | May 2025 | |
| NCT02202590 | Active, not recruiting | N/A | Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus | October 2013 | December 2027 |
| NCT02008903 | Active, not recruiting | Esophageal String Test in Eosinophilic Esophagitis | January 2009 | January 2025 | |
| NCT05634746 | Active, not recruiting | Phase 3 | 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3) | December 29, 2022 | March 2025 |
| NCT05176262 | Active, not recruiting | A Prospective Study of the Four Food Elimination Diet for Treatment of Eosinophilic Esophagitis | July 2011 | December 2024 | |
| NCT01921686 | Active, not recruiting | Morphological Markers of Gastroesophageal Reflux Disease (GERD) | March 2013 | February 2025 | |
| NCT05176249 | Active, not recruiting | Prospective Database for Eosinophilic Esophagitis (EoE) of Pediatric Population | October 2011 | October 2025 | |
| NCT05482256 | Active, not recruiting | N/A | A Study of Detergents in the Pathogenesis of Eosinophilic Esophagitis | September 12, 2022 | July 2024 |
| NCT01988285 | Active, not recruiting | Risk Factors and Biomarkers for Diagnosis and Treatment of EoE | July 2011 | August 2025 | |
| NCT05095116 | Available | Expanded Access Protocol for Patients With Eosinophilic Esophagitis | |||
| NCT01016223 | Completed | Phase 1 | A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis | March 2010 | October 2012 |
| NCT01022970 | Completed | Phase 2 | Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis | November 2009 | |
| NCT01040598 | Completed | Phase 1 | Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model | June 2009 | |
| NCT01056783 | Completed | Phase 2 | Proof of Concept Study of OC000459 in Eosinophilic Esophagitis | August 2010 | June 2011 |
| NCT01170234 | Completed | Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis | August 2010 | February 2012 | |
| NCT01234376 | Completed | Confocal Laser Endomicroscopy in Patients With Eosinophilic Esophagitis | November 2010 | December 2014 | |
| NCT01323803 | Completed | Eosinophilic Esophagitis Databank | April 2011 | February 2016 | |
| NCT01382563 | Completed | Registry for Eosinophilic Gastrointestinal Disorders (REGID) | November 2012 | December 2016 | |
| NCT01386112 | Completed | Phase 1/Phase 2 | Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis | September 2011 | October 2012 |
| NCT01498497 | Completed | A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021 | January 2012 | April 2013 | |
| NCT01631591 | Completed | Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis | May 2011 | July 2014 | |
| NCT01641913 | Completed | Phase 1 | Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients | August 2012 | February 2014 |
| NCT01808196 | Completed | Phase 2 | Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD | October 10, 2013 | February 13, 2015 |
| NCT01846962 | Completed | Phase 4 | Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis | November 2012 | June 2013 |
| NCT01897506 | Completed | Assessing Risk of Food Insecurity Within Households of Children With Food Allergy | June 2013 | August 20, 2018 | |
| NCT00266565 | Completed | Phase 1/Phase 2 | Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome | December 2001 | April 2005 |
| NCT01953575 | Completed | N/A | Mucosal Impedance and Eosinophilic Esophagitis | September 2013 | June 10, 2019 |
| NCT01999439 | Completed | N/A | EoE(Eosinophilic Esophagitis) | January 2014 | April 2016 |
| NCT01929824 | Completed | Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE) | August 2013 | September 25, 2019 | |
| NCT00266578 | Completed | Phase 3 | A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders | October 2002 | October 2012 |
| NCT00267475 | Completed | Data Bank for Eosinophilic Disorders | May 2001 | December 2012 | |
| NCT00271349 | Completed | Phase 2 | Budesonide for Eosinophilic Esophagitis | December 2005 | December 2008 |
| NCT00275561 | Completed | Phase 2 | Topical Steroid Treatment for Eosinophilic Esophagitis | November 2005 | April 2010 |
| NCT00426283 | Completed | Phase 2 | A Study of Flovent in Patients With Eosinophilic Esophagitis | January 2007 | March 2012 |
| NCT00511316 | Completed | Phase 1 | Trial of Montelukast in Eosinophilic Esophagitis | August 2007 | September 2015 |
| NCT00538434 | Completed | Phase 2/Phase 3 | Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years | March 2008 | October 2009 |
| NCT00635089 | Completed | Phase 3 | Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis | July 2008 | January 2012 |
| NCT00638456 | Completed | Phase 2 | Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis | February 2008 | September 2009 |
| NCT00667524 | Completed | Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation | February 2008 | March 2009 | |
| NCT00728481 | Completed | Phase 2/Phase 3 | The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis | May 2008 | December 2010 |
| NCT00895817 | Completed | N/A | Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis | April 2008 | October 2010 |
| NCT00961233 | Completed | N/A | Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE) | October 2009 | November 2011 |
| NCT02019758 | Completed | Phase 4 | Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis | January 1, 2015 | April 2019 |
| NCT02038894 | Completed | N/A | Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies | December 2009 | November 2013 |
| NCT02072590 | Completed | Improved Diagnostics of Celiac Disease in Children | August 2011 | November 21, 2023 | |
| NCT02098473 | Completed | Phase 2 | Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis | August 31, 2014 | January 30, 2017 |
| NCT02125851 | Completed | N/A | Comparison of Esophageal Clearance Times of Oral Budesonide Preparations | January 2014 | February 2014 |
| NCT02190513 | Completed | Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease | February 2011 | ||
| NCT02204150 | Completed | N/A | Study to Image the Esophagus Using the OFDI Capsule | February 2012 | July 2016 |
| NCT02227836 | Completed | N/A | Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis | August 2014 | September 2017 |
| NCT02280616 | Completed | Phase 2 | Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis | June 2011 | May 2014 |
| NCT02353078 | Completed | Early Phase 1 | The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis | January 2015 | December 2016 |
| NCT02371941 | Completed | Phase 4 | Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis | December 2014 | December 2017 |
| NCT02379052 | Completed | Phase 2 | Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE) | May 12, 2015 | July 10, 2017 |
| NCT02434029 | Completed | Phase 3 | Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis | November 11, 2015 | October 4, 2016 |
| NCT02434705 | Completed | Food Antigen in Eosinophilic Esophagitis | April 1, 2015 | December 8, 2023 | |
| NCT02493335 | Completed | Phase 3 | Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis | January 15, 2016 | December 11, 2020 |
| NCT02546219 | Completed | a4b7 Integrin in Eosinophilic Esophagitis | March 2016 | December 31, 2018 | |
| NCT02579876 | Completed | Phase 2 | Milk Patch for Eosinophilic Esophagitis | October 2015 | November 20, 2018 |
| NCT02599558 | Completed | N/A | Cytosponge and Dietary Therapy in EoE | November 2015 | January 8, 2022 |
| NCT02610816 | Completed | Phase 2/Phase 3 | Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids | March 21, 2016 | May 16, 2018 |
| NCT02722148 | Completed | N/A | Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET) | April 21, 2016 | April 2018 |
| NCT02775045 | Completed | Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis | August 30, 2016 | December 13, 2018 | |
| NCT02897271 | Completed | Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort | August 2016 | May 2020 | |
| NCT02995395 | Completed | Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE) | October 1, 2017 | August 31, 2020 | |
| NCT03029091 | Completed | Phase 2 | An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) | May 23, 2017 | August 22, 2019 |
| NCT03069573 | Completed | Phenotypic Characterization and Biomarkers Investigation for Eosinophilic Esophagitis in Pediatric Patients | January 1, 2015 | September 30, 2019 | |
| NCT03078023 | Completed | N/A | Sponge and Eosinophil Peroxidase (EPO) Staining | March 8, 2017 | July 19, 2019 |
| NCT03107819 | Completed | Metabolomics for Biomarker Discovery in Children With EoE | March 29, 2017 | March 31, 2018 | |
| NCT03191864 | Completed | Phase 2 | Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) | June 22, 2017 | October 23, 2019 |
| NCT03290482 | Completed | Natural History of Eosinophilic Esophagitis | June 19, 2017 | March 25, 2020 | |
| NCT03305653 | Completed | N/A | Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis | May 1, 2018 | March 1, 2019 |
| NCT03342391 | Completed | N/A | CEGIR 7808: Use of Unsedated Transnasal Esophagoscopy (TNE) to Monitor Dietary Management of Eosinophilic Esophagitis in Children | October 1, 2017 | September 1, 2020 |
| NCT03382678 | Completed | CEGIR 7807: Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact Registry | September 4, 2018 | July 1, 2020 | |
| NCT03633617 | Completed | Phase 3 | Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) | September 24, 2018 | June 7, 2022 |
| NCT03640975 | Completed | Innate Immunity in Eosinophilic Esophagitis | July 11, 2018 | October 28, 2019 | |
| NCT03656380 | Completed | Phase 2 | Mepo for Eosinophilic Esophagitis (EoE) Study | March 20, 2019 | December 9, 2022 |
| NCT03657771 | Completed | N/A | A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis | November 12, 2018 | December 31, 2023 |
| NCT03812575 | Completed | The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Pilot) | January 31, 2019 | June 1, 2020 | |
| NCT04069429 | Completed | Early Phase 1 | Radiation Dose in Humans From Orally Administered Tc99m-Heparin | July 2016 | October 2020 |
| NCT04281108 | Completed | Phase 3 | Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) | January 30, 2020 | October 24, 2022 |
| NCT04309786 | Completed | Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic Esophagitis | April 11, 2019 | April 26, 2021 | |
| NCT04311970 | Completed | N/A | Pilot Study of Esocheck in Eosinophilic Esophagitis | August 5, 2020 | August 23, 2021 |
| NCT04322708 | Completed | Phase 2/Phase 3 | A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis | July 6, 2020 | January 18, 2022 |
| NCT04593251 | Completed | Phase 1 | Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis | September 28, 2020 | April 2, 2024 |
| NCT04682639 | Completed | Phase 2 | A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis | December 15, 2020 | June 30, 2023 |
| NCT04704752 | Completed | Swallowing Characteristics of Pediatric Patients With Eosinophilic Esophagitis | May 25, 2020 | May 20, 2021 | |
| NCT04849390 | Completed | Phase 2 | A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis | June 29, 2021 | October 9, 2023 |
| NCT04941742 | Completed | The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase) | September 22, 2020 | December 22, 2021 | |
| NCT05083312 | Completed | Phase 3 | Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial | September 30, 2021 | September 5, 2022 |
| NCT05084963 | Completed | Phase 2 | A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis | October 29, 2021 | October 24, 2022 |
| NCT05444543 | Completed | Phase 4 | Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis) | November 17, 2021 | October 13, 2023 |
| NCT05488405 | Completed | Phase 2 | Mesalazine Oral Suspension in Active Eosinophilic Esophagitis | February 9, 2023 | July 20, 2023 |
| NCT01832324 | Enrolling by invitation | Molecular Basis of Food Allergy | January 2011 | December 2030 | |
| NCT05606705 | Enrolling by invitation | N/A | A Study of Baked Milk Tolerance to Treat Eosinophilic Esophagtis | December 5, 2022 | December 2024 |
| NCT05543512 | Enrolling by invitation | N/A | The Immune Directed Individualized Elimination Therapy (iDIET) Study | October 14, 2022 | January 30, 2025 |
| NCT03546660 | Not yet recruiting | N/A | Imaging of the Esophagus Using a SECM Capsule | January 1, 2025 | December 30, 2027 |
| NCT06443346 | Not yet recruiting | Prospective Registry of EoSinophilic esOphagitis | June 1, 2024 | December 31, 2044 | |
| NCT05896891 | Not yet recruiting | San Raffaele EoE Biobank | September 12, 2023 | June 1, 2026 | |
| NCT05214599 | Not yet recruiting | Phase 2 | Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE) | July 31, 2024 | April 30, 2025 |
| NCT06071585 | Not yet recruiting | Monocentric Retrospective Observational Study for Validation of Meta-analysis of the Metatrascryptome and Transcriptome of Eosynophyl Esophagitis | November 1, 2023 | November 1, 2024 | |
| NCT06352073 | Not yet recruiting | Phase 4 | Dupilumab for Eosinophilic Esophagitis With Severe Strictures | April 2024 | April 2026 |
| NCT06387030 | Not yet recruiting | N/A | EDN and Eosinophilic Esophagitis | April 2024 | April 2026 |
| NCT05594849 | Not yet recruiting | Evaluation of Efficacy, Safety and Patient' Satisfaction of Therapeutic Switch From Off-Steroids to Budesonide | December 1, 2022 | June 30, 2023 | |
| NCT04653324 | Recruiting | A Registry for the Food Allergy Community | August 24, 2017 | August 2027 | |
| NCT05900011 | Recruiting | Validation in French of a Quality of Life Questionnaire for Patients With Eosinophilic Esophagitis in Pediatrics | July 17, 2023 | December 2024 | |
| NCT02523118 | Recruiting | OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages | July 17, 2015 | January 1, 2051 | |
| NCT05622214 | Recruiting | N/A | The Efficacy and Tolerability of 12-weeks Treatment With Almond and Buckwheat Based Formula in Pediatric Patients With Active EoE | July 25, 2022 | December 31, 2023 |
| NCT03980886 | Recruiting | Characteristics and Inflammatory Markers in Children With Eosinophilic Esophagitis (EoE) | February 11, 2019 | December 17, 2028 | |
| NCT05695456 | Recruiting | Phase 1/Phase 2 | Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy | February 16, 2022 | December 2023 |
| NCT04149470 | Recruiting | Phase 4 | Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE) | October 7, 2020 | August 2024 |
| NCT05730933 | Recruiting | N/A | An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis. | April 12, 2023 | December 2024 |
| NCT05755477 | Recruiting | Survey About the Relationship Beetween Allergic Rhinitis and Seasonal EOE Exacerbations | January 3, 2021 | December 31, 2023 | |
| NCT05757856 | Recruiting | Phase 1 | A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis | January 20, 2023 | September 2024 |
| NCT05774184 | Recruiting | Phase 2 | A Study of CDX-0159 in Patients With Eosinophilic Esophagitis | June 1, 2023 | August 2025 |
| NCT04416217 | Recruiting | Eosinophilic Esophagitis Steroid Safety Study | October 7, 2019 | December 31, 2025 | |
| NCT04506593 | Recruiting | Indiana University Gastrointestinal Motility Diagnosis Registry | November 2014 | November 2024 | |
| NCT06159218 | Recruiting | N/A | Eosinophilic Oesophagitis Assessment With String Testing | November 9, 2022 | December 31, 2023 |
| NCT06187753 | Recruiting | Sensory Processing Issues in Eosinophilic Esophagitis | August 20, 2023 | July 20, 2024 | |
| NCT04991935 | Recruiting | Phase 3 | Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis | September 14, 2021 | September 29, 2026 |
| NCT06381219 | Recruiting | N/A | Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot Trial | December 19, 2023 | December 31, 2028 |
| NCT02453126 | Recruiting | Fibrostenotic Eosinophilic Esophagitis: Assessment Tools | December 2014 | June 2024 | |
| NCT05175352 | Recruiting | Phase 1 | A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab | June 7, 2022 | January 25, 2025 |
| NCT02504853 | Recruiting | Natural History and Genetics of Food Allergy and Related Conditions | July 29, 2015 | June 15, 2025 | |
| NCT05608681 | Recruiting | Phase 1/Phase 2 | A Trial to Evaluate EP-104IAR in Adults With Eosinophilic Esophagitis (EoE). | March 31, 2023 | November 2024 |
| NCT05180578 | Recruiting | N/A | Tolerability of Goat Milk Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein Trigger | November 12, 2020 | March 2025 |
| NCT05199532 | Recruiting | Eosinophilic Gastrointestinal Disorders Registry | December 18, 2020 | December 2035 | |
| NCT05219903 | Recruiting | National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders | January 20, 2022 | January 31, 2027 | |
| NCT02873468 | Recruiting | Phase 2 | Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis | April 19, 2021 | November 2025 |
| NCT05246085 | Recruiting | Evaluating Adrenal Insufficiency in Adults With Eosinophilic Esophagitis on Chronic Swallowed Topical Steroids | August 10, 2022 | July 1, 2023 | |
| NCT05485155 | Recruiting | Phase 2 | Zemaira Eosinophilic Esophagitis Pilot Study | March 1, 2024 | March 1, 2025 |
| NCT03312686 | Recruiting | Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study | November 2016 | December 31, 2025 | |
| NCT05583227 | Recruiting | Phase 3 | Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis | November 10, 2022 | January 8, 2027 |
| NCT01404832 | Terminated | Phase 4 | The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors | October 2007 | May 2010 |
| NCT01814059 | Terminated | Phase 1 | Sirolimus for Eosinophil-Associated Gastrointestinal Disorders | March 7, 2013 | May 12, 2015 |
| NCT01585103 | Terminated | N/A | Cytosponge Protocol IRB 11-006429 | December 2012 | June 7, 2016 |
| NCT05579444 | Terminated | Systems Biology of Gastrointestinal and Related Diseases | November 11, 2022 | November 29, 2023 | |
| NCT04248712 | Terminated | Phase 2 | Antihistamines in Eosinophilic Esophagitis | July 10, 2020 | December 31, 2021 |
| NCT03446118 | Terminated | N/A | MRI to Assess Fibrosis in Eosinophilic Esophagitis Patients | March 1, 2017 | April 15, 2019 |
| NCT01212016 | Terminated | Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders | August 30, 2010 | May 13, 2015 | |
| NCT02113267 | Terminated | Phase 2 | Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study. | April 2014 | September 2018 |
| NCT02114606 | Terminated | N/A | Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge | July 2015 | June 2016 |
| NCT01821898 | Terminated | Phase 2 | Eosinophilic Esophagitis Clinical Therapy Comparison Trial | July 9, 2013 | September 24, 2018 |
| NCT01458418 | Terminated | N/A | A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children | December 2011 | February 2015 |
| NCT02314455 | Terminated | N/A | Esophageal Absorption in EoE | September 2014 | July 2016 |
| NCT02354716 | Terminated | EndoFLIP Use in Upper GI Tract Stenosis | December 2014 | January 2019 | |
| NCT04543409 | Terminated | Phase 3 | A Study of Benralizumab in Patients With Eosinophilic Esophagitis | September 22, 2020 | February 6, 2023 |
| NCT03615950 | Unknown status | Effects of Swallowed Steroids on Bone Density and Growth in Pediatric Eosinophilic Esophagitis | October 1, 2019 | October 1, 2020 | |
| NCT01624129 | Unknown status | New Serological Markers for Eosinophilic Esophagitis | January 2011 | ||
| NCT04769232 | Unknown status | N/A | Endoscopic Characterisation of Inflammation in EoE | March 2021 | November 2021 |
| NCT04803162 | Unknown status | The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE | November 14, 2017 | December 2021 | |
| NCT05342168 | Unknown status | N/A | Comparison of Histology From a Mesh Sponge and Traditional Esophageal Biopsies in Children and Adolescents With EoE | April 1, 2022 | September 1, 2023 |
| NCT02331849 | Unknown status | N/A | Esophageal Motility in Eosinophilic Esophagitis Evaluated by High Resolution Manometry. | October 2013 | |
| NCT03781596 | Unknown status | Phase 4 | EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone | October 2, 2018 | October 2, 2022 |
| NCT04671446 | Unknown status | Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma | December 10, 2020 | June 2022 | |
| NCT03858426 | Unknown status | Prospective Multicenter Nationwide Registry of Children With Eosinophilic Esophagitis | January 1, 2019 | July 30, 2022 | |
| NCT02881372 | Withdrawn | N/A | EoE Food Desensitization | August 8, 2018 | May 2023 |
| NCT01479231 | Withdrawn | Phase 1/Phase 2 | Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis | March 2012 | March 2012 |
| NCT01779154 | Withdrawn | Eosinophilic Gastrointestinal Disorders Patient Registry | January 2013 | May 2017 | |
| NCT01685034 | Withdrawn | N/A | Allergy Immunotherapy in the Management of Eosinophilic Esophagitis | ||
| NCT03834298 | Withdrawn | N/A | Non-endoscopic Tracking of Disease Activity in Eosinophilic Esophagitis | June 1, 2021 | December 1, 2023 |
| NCT01702701 | Withdrawn | Phase 3 | Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone | January 2012 | July 20, 2017 |
| NCT03803527 | Withdrawn | N/A | Metabolomic Profiling of Eosinophilic Esophagitis | December 1, 2019 | August 1, 2021 |
| NCT03354221 | Withdrawn | N/A | Short Duration 6Fed Sponge For EoE Patients | August 2017 | March 15, 2019 |
| NCT04835168 | Withdrawn | Phase 1 | Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis | January 30, 2022 | June 30, 2022 |
- Disase is a (Disease Ontology)
- DOID:11963
- Cross Reference ID (Disease Ontology)
- EFO:0004232
- Cross Reference ID (Disease Ontology)
- ICD10CM:K20.0
- Cross Reference ID (Disease Ontology)
- ICD9CM:530.13
- Cross Reference ID (Disease Ontology)
- MESH:D057765
- Cross Reference ID (Disease Ontology)
- MIM:610247
- Cross Reference ID (Disease Ontology)
- MIM:613412
- Cross Reference ID (Disease Ontology)
- NCI:C27105
- Cross Reference ID (Disease Ontology)
- ORDO:73247
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:235599003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0341106
- OrphaNumber from OrphaNet (Orphanet)
- 73247
- MedGen concept unique identifier (MedGen Concept name)
- C0341106
- MedGen unique identifier (MedGen Concept name)
- 83318
- MeSH unique ID (MeSH (Medical Subject Headings))
- D057765